Diagnosis and treatment of unexplained anemia with iron deficiency without overt bleeding.
Study Goal
The researchers aimed to identify benign gastrointestinal causes of anemia, including iron malabsorption due to bariatric surgery, and recommend diagnostic strategies for unexplained anemia with iron deficiency.
Results Summary
The study identified bariatric surgery as a benign gastrointestinal cause of iron malabsorption leading to anemia but did not provide specific efficacy or safety data on the procedure itself. It recommended diagnostic steps and iron supplementation for such cases.
Population
Patients with unexplained anemia and iron deficiency, including those with a history of bariatric surgery.
Effective Dosage
Not specified for bariatric surgery (iron supplementation: 100-200 mg daily elemental iron).
Duration
Not specified for bariatric surgery (iron therapy: 3-6 months).
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
iron supplementation | increase | hemoglobin levels and replenishing iron stores | - | normalizing | should be administered, with the goal of normalizing | #1 |
Oral treatment with a 100-200 mg daily dose of elemental iron | neutral | - | - | 100-200 mg daily dose | is recommended | #2 |
oral iron therapy | neutral | - | - | 3-6 months | is often required to achieve therapeutic goals | #3 |
Intravenous iron therapy | neutral | - | - | - | is used if oral treatment lacks efficacy or causes side effects or in the presence of intestinal malabsorption or prolonged inflammation | #4 |
A general overview is given of the causes of anemia with iron deficiency as well as the pathogenesis of anemia and the para-clinical diagnosis of anemia. Anemia with iron deficiency but without overt GI bleeding is associated with a risk of malignant disease of the gastrointestinal tract; upper gastrointestinal cancer is 1/7 as common as colon cancer. Benign gastrointestinal causes of anemia are iron malabsorption (atrophic gastritis, celiac disease, chronic inflammation, and bariatric surgery) and chronic blood loss due to gastrointestinal ulcerations. The following diagnostic strategy is recommended for unexplained anemia with iron deficiency: conduct serological celiac disease screening with transglutaminase antibody (IgA type) and IgA testing and perform bidirectional endoscopy (gastroscopy and colonoscopy). Bidirectional endoscopy is not required in premenopausal women < 40 years of age. Small intestine investigation (capsule endoscopy, CT, or MRI enterography) is not recommended routinely after negative bidirectional endoscopy but should be conducted if there are red flags indicating malignant or inflammatory small bowel disease (e.g., involuntary weight loss, abdominal pain or increased CRP). Targeted treatment of any cause of anemia with iron deficiency found on diagnostic assessment should be initiated. In addition, iron supplementation should be administered, with the goal of normalizing hemoglobin levels and replenishing iron stores. Oral treatment with a 100-200 mg daily dose of elemental iron is recommended (lower dose if side effects), but 3-6 months of oral iron therapy is often required to achieve therapeutic goals. Intravenous iron therapy is used if oral treatment lacks efficacy or causes side effects or in the presence of intestinal malabsorption or prolonged inflammation. Three algorithms are given for the following conditions: a) the paraclinical diagnosis of anemia with iron deficiency; b) the diagnostic work-up for unexplained anemia with iron deficiency without overt bleeding; and c) how to proceed after negative bidirectional endoscopy of the gastrointestinal tract.